-transparent.png){kind=logo}
The purpose of this study was to determine the receptor subtype(s) that mediates tachykinin-induced neurogenic plasma extravasation in the hamster cheek pouch. Changes in microvascular clearance were quantified by counting the number of leaky sites and calculating the clearance of fluorescein isothiocyanate-dextran [mol wt 70,000 (Dextran 70)] during suffusion of the cheek pouch with substance P, neurokinin A, neurokinin B, and capsaicin. Suffusion of substance P, capsaicin, and neurokinin A, but not neurokinin B, was associated with a significant concentration-dependent increase in leaky site formation and clearance of fluorescein isothiocyanate-Dextran 70 (P < 0.05). However, the responses to substance P and capsaicin were significantly greater than those to neurokinin A. Pretreatment with the selective, nonpeptide NK1 receptor antagonist, CP-96,345, significantly attenuated substance P- and capsaicin-induced but not neurokinin A-induced responses (P < 0.05). These effects were specific, since the 2R,3R enantiomer, CP-96,344, was inactive, and CP-96,345 had no significant effect on adenosine-induced responses. We conclude that, in the hamster cheek pouch, NK1 receptors are the predominant receptors that mediate neurogenic plasma extravasation.
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
September 1994,
Journal of immunology (Baltimore, Md. : 1950),
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
November 1993,
Agents and actions,
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
October 1993,
The American review of respiratory disease,
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
January 2013,
Clinical hemorheology and microcirculation,
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
January 1990,
Advances in prostaglandin, thromboxane, and leukotriene research,
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
January 1987,
Advances in prostaglandin, thromboxane, and leukotriene research,
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
October 1994,
British journal of pharmacology,
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
March 1985,
Kanagawa shigaku. The Journal of the Kanagawa Odontological Society,
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
June 1991,
Inflammation,
X P Gao, and
R A Robbins, and
R M Snider, and
J Lowe, and
S I Rennard, and
P Anding, and
I Rubinstein
January 1997,
The Kurume medical journal,
